1
Clinical Trials associated with YYC-405A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of YYC405-T Added to Metformin and Dapagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control With the Combination of Metformin and Dapagliflozin
Phase 3 study to assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients
100 Clinical Results associated with YYC-405
100 Translational Medicine associated with YYC-405
100 Patents (Medical) associated with YYC-405
100 Deals associated with YYC-405